Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Income towards Parent Company (2023 - 2025)

SeaStar Medical Holding filings provide 3 years of Income towards Parent Company readings, the most recent being -$2.9 million for Q4 2025.

  • On a quarterly basis, Income towards Parent Company rose 34.28% to -$2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.1 million, a 51.07% increase, with the full-year FY2025 number at -$12.1 million, up 51.07% from a year prior.
  • Income towards Parent Company hit -$2.9 million in Q4 2025 for SeaStar Medical Holding, up from -$3.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$2.0 million in Q2 2025 to a low of -$12.7 million in Q1 2024.
  • Median Income towards Parent Company over the past 3 years was -$4.1 million (2024), compared with a mean of -$5.3 million.
  • Biggest five-year swings in Income towards Parent Company: plummeted 78.93% in 2024 and later soared 70.29% in 2025.
  • SeaStar Medical Holding's Income towards Parent Company stood at -$9.5 million in 2023, then soared by 53.27% to -$4.4 million in 2024, then skyrocketed by 34.28% to -$2.9 million in 2025.
  • The last three reported values for Income towards Parent Company were -$2.9 million (Q4 2025), -$3.5 million (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.